For example, miR-449a has been reported to target EME1 and downregulate BRCA2 and RAD51 in breast cancer (Table 2), while miR-146 targets and/or downregulates FANCM and BRCA1 in cervical, gastric, and breast cancer cells (Table 1). This evidence concerns the gene BRCA2 and breast cancer.